Clinical Trial

Calibr-Ì: Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans

Study acronym: Calibr-Ì
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Osteoporosis is a systemic disease characterized by a reduction in bone mineral density (BMD) and qualitative alteration of the skeleton, resulting in increased bone fragility and fracture risk. The epidemiological impact of osteoporosis is extremely high. Proper diagnosis and clinical management of osteoporosis are critical to reducing the incidence of fragility fractures and preventing their complications. The diagnosis is generally confirmed by instrumental analysis of bone mineral density. The standard method is X-ray bone densitometry (DXA), which allows diagnosis based on criteria defined by the World Health Organization (WHO) by virtue of the T-score. DXA is a relatively quick and inexpensive examination with low exposure to ionizing radiation. However, this method has limitations in detecting fracture risk, and in addition, not all patients are properly referred for DXA services, which, among other things, require specific criteria to be reimbursed by the National Health System. Currently, computed tomography (CT) scanning is the most widely used three-dimensional diagnostic modality in clinical practice, and the number of investigations performed in high-income countries is continuously growing. Quantitative assessment of bone mineral density by CT is possible by proper calibration of the machine for the purpose of converting the CT numbers (or Hounsfield units) measured by the scanner into BMD units.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-06.
Trial Details
NCT Number NCT06454617
Lead Sponsor Istituto Ortopedico Rizzoli
Collaborators: Auckland Hospital - Greenlane Clinical Centre - National Women's Hospital
Conditions Osteoporosis
Enrollment 100 participants
Start Date 2024-06-06
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-06-10